[ad_1]
(MedPage Today) — For patients with moderate to severe acute respiratory distress syndrome (ARDS), prolonged sedation with the inhaled volatile agent sevoflurane resulted in worse outcomes than intravenous propofol, the randomized SESAR trial…
[ad_2]
Source link : https://www.medpagetoday.com/pulmonology/generalpulmonary/114727
Author :
Publish date : 2025-03-19 14:31:00
Copyright for syndicated content belongs to the linked Source.
ARDS Outcomes Better With Intravenous vs Inhaled Sedative
Related Posts
